View in EDS PDF Full Text

Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.

Saved in:
Bibliographic Details
Title: Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.
Authors: Marks JA; Dana-Farber Cancer Institute, Boston, MA., Ahn J; Georgetown University, Washington, DC., Reuss JE; Georgetown University, Washington, DC., Barbie D; Dana-Farber Cancer Institute, Boston, MA., Altan M; The University of Texas MD Anderson Cancer Center, Houston, TX., Gutierrez ME; Hackensack University Medical Center, Hackensack, NJ., Garassino MC; University of Chicago, Chicago, IL., Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY., Wakelee H; Stanford University, Stanford, CA., Liu SV; Georgetown University, Washington, DC., Kim C; Georgetown University, Washington, DC. Electronic address: chul.kim@gunet.georgetown.edu.
Source: Clinical lung cancer [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 165-167. Date of Electronic Publication: 2024 Dec 04.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39753485
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Marks+JA%22">Marks JA</searchLink>; Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ahn+J%22">Ahn J</searchLink>; Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Reuss+JE%22">Reuss JE</searchLink>; Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Barbie+D%22">Barbie D</searchLink>; Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Altan+M%22">Altan M</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Gutierrez+ME%22">Gutierrez ME</searchLink>; Hackensack University Medical Center, Hackensack, NJ.<br /><searchLink fieldCode="AU" term="%22Garassino+MC%22">Garassino MC</searchLink>; University of Chicago, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Riely+GJ%22">Riely GJ</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Wakelee+H%22">Wakelee H</searchLink>; Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Liu+SV%22">Liu SV</searchLink>; Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Kim+C%22">Kim C</searchLink>; Georgetown University, Washington, DC. Electronic address: chul.kim@gunet.georgetown.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2025 May; Vol. 26 (3), pp. 165-167. <i>Date of Electronic Publication: </i>2024 Dec 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39753485
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2024.12.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 165
    Titles:
      – TitleFull: Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marks JA
      – PersonEntity:
          Name:
            NameFull: Ahn J
      – PersonEntity:
          Name:
            NameFull: Reuss JE
      – PersonEntity:
          Name:
            NameFull: Barbie D
      – PersonEntity:
          Name:
            NameFull: Altan M
      – PersonEntity:
          Name:
            NameFull: Gutierrez ME
      – PersonEntity:
          Name:
            NameFull: Garassino MC
      – PersonEntity:
          Name:
            NameFull: Riely GJ
      – PersonEntity:
          Name:
            NameFull: Wakelee H
      – PersonEntity:
          Name:
            NameFull: Liu SV
      – PersonEntity:
          Name:
            NameFull: Kim C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1